michael barry
Senior Member
- Reaction score
- 12
http://www.intercytex.com/icx/investors ... -06-29.pdf
Thats the ICX investor report for 2006. It describes the timeline for their woundcare stem-cell products, stem-cell burn tissue products, stem-cell diabetic sore products, stem-cell facial rejuvination products, and finally the stem-cell hair regeneration products.
ICX is claiming that ICX-TRC may be available as sometime in year 2008 (I suspect late in the year) in England. The product will first be offered for licensing rights to Bosley as per a previous agreement with them for sale here stateside. I still think it may be about 2010, and believe this to be a very optomistic assesment.
However, there need not be phase 3 trials for this product to be sold outside the United States, so it could be a go. Phase 2 trials are about to commence over there, and we should see new hair sprouting from trialees in about 3, 4, or 5 months. They will know if they have a real winner if alot of hair grows. They seem awfully confident about this (I imagine they have been testing on human skin grafted onto immuno deficient mice for some time now). Who knows? It seems like an exciting company in that their products are going to really help people and none of their stem cell derived therapies have caused any cancers, or other disorders so far.
Thats the ICX investor report for 2006. It describes the timeline for their woundcare stem-cell products, stem-cell burn tissue products, stem-cell diabetic sore products, stem-cell facial rejuvination products, and finally the stem-cell hair regeneration products.
ICX is claiming that ICX-TRC may be available as sometime in year 2008 (I suspect late in the year) in England. The product will first be offered for licensing rights to Bosley as per a previous agreement with them for sale here stateside. I still think it may be about 2010, and believe this to be a very optomistic assesment.
However, there need not be phase 3 trials for this product to be sold outside the United States, so it could be a go. Phase 2 trials are about to commence over there, and we should see new hair sprouting from trialees in about 3, 4, or 5 months. They will know if they have a real winner if alot of hair grows. They seem awfully confident about this (I imagine they have been testing on human skin grafted onto immuno deficient mice for some time now). Who knows? It seems like an exciting company in that their products are going to really help people and none of their stem cell derived therapies have caused any cancers, or other disorders so far.